Alembic Pharma gets USFDA’s nod for anti-inflammatory drug: Report

26 Jun 2015 Evaluate

Alembic Pharmaceuticals has reportedly received tentative approval from US Food and Drug Administration (USFDA) for its anti-inflammatory drug. The pharma company has received tentative approval from USFDA for Celecoxib oral capsules, 50 mg, 100mg, 200 mg, 400 mg. GD Searle LLC division of Pfizer Inc is the innovator of this drug. Companies like Teva, Mylan, Watson, Lupin and Apotex have been selling Celecoxib drug, which is one of Pfizer's billion dollar drugs and has a $2 billion size.

Alembic Pharmaceuticals, a vertically integrated research and development pharmaceutical company, has been at the forefront of Healthcare since 1907. The company manufactures and markets generic pharmaceuticals products all over the world.

Alembic Pharma Share Price

1043.90 5.70 (0.55%)
22-Nov-2024 12:45 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1782.85
Dr. Reddys Lab 1211.05
Cipla 1487.85
Lupin 2061.30
Zydus Lifesciences 945.85
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.